Early Trial Findings Hint at SNG001 Aiding COPD Patients with Viral Infections - COPD News Today
Early Trial Findings Hint at SNG001 Aiding COPD Patients with Viral Infections COPD News Today
Early findings in a Phase 2 trial of SNG001, an inhaled therapy for viral infections in COPD patients, show flu and colds considerably worsen symptoms.
Comments
Post a Comment